Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Mediterr J Hematol Infect Dis. 2013 Sep 2;5(1):e2013057. doi: 10.4084/MJHID.2013.057.

Vitamin d status in thalassemia major: an update.

Author information

1
Departments of Pediatrics, Hamad Medical Center (HMC), Doha (Qatar).

Abstract

The survival of patients with thalassemia major has progressively improved with advances in therapy; however, osteoporosis and cardiac dysfunction remain frequent complications. Adequate circulating levels of vitamin D are essential for optimal skeletal health and reducing fracture risk. Vitamin D deficiency and insufficiency is reported to be high in thalassemic patients in many countries despite the presence of good sunshine and routine prescription of 400-1,000 IU vitamin D per day. The risk of vitamin D deficiency in thalassemia and its relation to bone disease; including osteoporosis, rickets, scoliosis, spinal deformities and fractures as well as to cardiac dysfunction is discussed in this mini-review. Monitoring and maintaining normal serum level of 25-OH vitamin D through oral intake of vitamin D and early correction of VDD by oral or parental use of vitamin D may significantly improve bone mineral accretion and ameliorate cardiac function.

Supplemental Content

Full text links

Icon for Catholic University in Rome, Institute of Hematology Icon for PubMed Central
Loading ...
Support Center